Story

InnovAge Shares Plunge After Major Stockholders Announce 10 Million Share Offering

ENTHMSVIIDZHZH-TWJAKOHI
Sep 22, 20261 min read
InnovAge Shares Plunge After Major Stockholders Announce 10 Million Share Offering

Summary

The healthcare provider's stock fell over 11% in after-hours trading after investment funds affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe launched a secondary public offering. InnovAge will not receive any proceeds from the sale.

Text size
Background

Shares of InnovAge Holding Corp. (NASDAQ:INNV) dropped sharply in after-hours trading on Tuesday after the company disclosed a significant secondary stock offering by some of its major existing shareholders. The stock fell 11.4% following the announcement.

Details of the Offering

The underwritten public offering consists of 10 million shares of InnovAge's common stock being sold by investment funds affiliated with private equity firms Apax Partners and Welsh, Carson, Anderson & Stowe, according to a company statement. InnovAge itself is not selling any shares and will not receive any of the proceeds from the transaction.

The selling stockholders have also granted the underwriters a 30-day option to purchase up to an additional 1.5 million shares. While InnovAge will not benefit financially from the sale, the company stated it will bear the associated costs, excluding underwriting discounts and commissions.

Sample IUX Markets – In-articleAd

Market Impact and Context

Secondary offerings can exert downward pressure on a company's stock price by increasing the public supply of shares available for trading. This potential for dilution often concerns existing investors. The sale by major private equity backers can also be interpreted by the market as an exit or a move to lock in profits.

The offering is being made pursuant to a registration statement on Form S-3 filed with the U.S. Securities and Exchange Commission. Barclays, Goldman Sachs & Co. LLC, and Wells Fargo Securities are acting as the joint book-running managers for the sale.

Read next

More on Stocks
Back to latest news

LATEST